Cargando…
SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1‐Dependent Manner
BACKGROUND: Pathological cardiac hypertrophy is regarded as a critical precursor and independent risk factor of heart failure, and its inhibition prevents the progression of heart failure. Switch‐associated protein 70 (SWAP70) is confirmed important in immunoregulation, cell maturation, and cell tra...
Autores principales: | Qian, Qiaofeng, Hu, Fengjiao, Yu, Wenjun, Leng, Dewen, Li, Yang, Shi, Hongjie, Deng, Dawei, Ding, Kehan, Liang, Chuan, Liu, Jinping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122912/ https://www.ncbi.nlm.nih.gov/pubmed/36974751 http://dx.doi.org/10.1161/JAHA.122.028628 |
Ejemplares similares
-
Switch‐associated protein 70 protects against nonalcoholic fatty liver disease through suppression of TAK1
por: Qian, Qiaofeng, et al.
Publicado: (2022) -
SWAP-70: A New Type of Oncogene
por: Shu, Chung-Li, et al.
Publicado: (2013) -
SWAP70 Organizes the Actin Cytoskeleton and Is Essential for Phagocytosis
por: Baranov, Maksim V., et al.
Publicado: (2016) -
The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
por: Ji, Yan-Xiao, et al.
Publicado: (2016) -
Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway
por: Liao, Hai-han, et al.
Publicado: (2019)